Epstein-Barr virus (EBV) infects most humans and persists lifelong within a dynamic equilibrium maintained by B-cell latency, cytotoxic T-cell control, NK-cell surveillance and humoral immunity. Ageing can remodel this equilibrium through thymic involution, contraction of the naive T-cell pool, accumulation of late-dif...
Yue Cao, Yan Liang, Chen-Xi Zhao et al.· Ageing Research Reviews· 0 citations
Chronic active Epstein-Barr virus disease (CAEBV) is a rare EBV-associated T/NK-cell lymphoproliferative disorder characterized by persistent viral infection, systemic inflammation, and highly variable clinical courses. Patients may develop HLH-like hyperinflammation, severe organ involvement, lymphoma transformati...
Yue Cao, Zhe Zhou, Sheng-Lei Yu et al.· Frontiers in Immunology· 0 citations
Background/Objectives: Virological findings during immune checkpoint inhibitor (ICI) therapy may represent viral loss of control, pre-existing infection, tumour biomarkers, or infection after immune-related adverse event (irAE)-directed immunosuppression. Distinguishing these possibilities is important for treatment an...
Yue Cao, Zeng-Hui Zhang, Yan Liang et al.· Pharmaceuticals· 0 citations
This study found five prognostic genes, with CXCR6 associated with Gαi, Src, and PI3K-AKT pathways in the modulation of THCA, indicating the essential function of CXCR6 in THCA.
Yi-Ting Yao, Lin-Lang Huang, R. Xia et al.· BMC Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.